TRACON Pharmaceuticals, Inc. (TCON)

TRACON Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	7.89	8.56	17.43	24.07	32.13	16.41
Short-Term Investments	0	0	0	0	4	0
Cash & Cash Equivalents	7.89	8.56	17.43	24.07	36.13	16.41
Cash Growth	19.38%	-50.87%	-27.58%	-33.37%	120.14%	-58.03%
Other Current Assets	0.51	0.53	0.8	0.86	0.78	0.85
Total Current Assets	8.4	9.09	18.23	24.94	36.91	17.26
Property, Plant & Equipment	0.03	0.94	0.05	0.05	0.02	0.02
Long-Term Investments	0.07	0.07	0.07	0.25	0	0
Other Long-Term Assets	0.85	0	1.12	1.33	0.51	0.84
Total Long-Term Assets	0.95	1.02	1.24	1.62	0.52	0.86
Total Assets	9.36	10.11	19.47	26.56	37.44	18.12
Accounts Payable	2.68	2.54	3.92	4.94	1.73	7.52
Deferred Revenue	0	0	0	0	0	-7.52
Current Debt	0	0.24	9.81	1.39	3.14	2.6
Other Current Liabilities	7.77	7.4	8.64	7.34	5.68	9.23
Total Current Liabilities	10.45	10.18	22.37	13.68	10.54	11.83
Long-Term Debt	0	0.73	0.97	1.17	1.39	2.74
Other Long-Term Liabilities	0.67	-0	3.28	0	0.43	0.85
Total Long-Term Liabilities	0.67	0.73	4.25	1.17	1.82	3.59
Total Liabilities	11.12	10.91	26.62	14.84	12.37	15.42
Total Debt	0	0.97	9.81	1.39	4.53	5.34
Debt Growth	-	-90.13%	605.03%	-69.27%	-15.27%	-16.87%
Common Stock	0	0.04	0.02	0.02	0.02	0
Retained Earnings	-243.67	-240.5	-236.91	-207.78	-179.11	-162.33
Comprehensive Income	0	0	0	0	0	0
Shareholders' Equity	-1.76	-0.81	-7.15	11.71	25.07	2.7
Total Liabilities and Equity	9.36	10.11	19.47	26.56	37.44	18.12
Net Cash / Debt	7.89	7.6	7.63	22.68	31.6	11.07
Net Cash / Debt Growth	31.30%	-0.39%	-66.38%	-28.23%	185.51%	-66.13%
Net Cash Per Share	3.30	0.23	0.36	1.31	3.52	3.65
Working Capital	-2.05	-1.09	-4.14	11.26	26.37	5.43
Book Value Per Share	-0.74	-0.02	-0.34	0.68	2.79	0.89

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.